BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 31243977)

  • 21. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
    Gao W; Xiang B; Meng TT; Liu F; Qi XR
    Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
    Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
    Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of N-terminal and C-terminal modification on cytotoxicity and cellular uptake of amphiphilic cell penetrating peptides.
    Soleymani-Goloujeh M; Nokhodchi A; Niazi M; Najafi-Hajivar S; Shahbazi-Mojarrad J; Zarghami N; Zakeri-Milani P; Mohammadi A; Karimi M; Valizadeh H
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):91-103. PubMed ID: 29258339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
    Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
    Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing Variants of the Cell-Penetrating Peptide sC18 to Design Peptide-Drug Conjugates.
    Grabeck J; Lützenburg T; Frommelt P; Neundorf I
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agents.
    He H; Sun L; Ye J; Liu E; Chen S; Liang Q; Shin MC; Yang VC
    J Control Release; 2016 Oct; 240():67-76. PubMed ID: 26514292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo near-infrared fluorescence imaging of integrin α2β1 in prostate cancer with cell-penetrating-peptide-conjugated DGEA probe.
    Huang CW; Li Z; Conti PS
    J Nucl Med; 2011 Dec; 52(12):1979-86. PubMed ID: 22065876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bifunctional peptide hybrids targeting the matrix of mitochondria.
    Klimpel A; Neundorf I
    J Control Release; 2018 Dec; 291():147-156. PubMed ID: 30367921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzyme-triggered delivery of chlorambucil from conjugates based on the cell-penetrating peptide BP16.
    Soler M; González-Bártulos M; Figueras E; Ribas X; Costas M; Massaguer A; Planas M; Feliu L
    Org Biomol Chem; 2015 Feb; 13(5):1470-80. PubMed ID: 25474438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclic dipeptide based cell-penetrating peptidomimetics for effective DNA delivery.
    Madhu C; Voshavar C; Rajasekhar K; Govindaraju T
    Org Biomol Chem; 2017 Apr; 15(15):3170-3174. PubMed ID: 28349160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A molecular toolkit for the functionalization of titanium-based biomaterials that selectively control integrin-mediated cell adhesion.
    Rechenmacher F; Neubauer S; Mas-Moruno C; Dorfner PM; Polleux J; Guasch J; Conings B; Boyen HG; Bochen A; Sobahi TR; Burgkart R; Spatz JP; Fässler R; Kessler H
    Chemistry; 2013 Jul; 19(28):9218-23. PubMed ID: 23744802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin α
    Raposo Moreira Dias A; Pina A; Dal Corso A; Arosio D; Belvisi L; Pignataro L; Caruso M; Gennari C
    Chemistry; 2017 Oct; 23(58):14410-14415. PubMed ID: 28816404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functionalized triazolopeptoids--a novel class for mitochondrial targeted delivery.
    Althuon D; Rönicke F; Fürniss D; Quan J; Wellhöfer I; Jung N; Schepers U; Bräse S
    Org Biomol Chem; 2015 Apr; 13(14):4226-30. PubMed ID: 25739445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and Biological Evaluation of RGD and isoDGR-Monomethyl Auristatin Conjugates Targeting Integrin α
    Raposo Moreira Dias A; Bodero L; Martins A; Arosio D; Gazzola S; Belvisi L; Pignataro L; Steinkühler C; Dal Corso A; Gennari C; Piarulli U
    ChemMedChem; 2019 May; 14(9):938-942. PubMed ID: 30840356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.
    Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X
    J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CyLoP-1: a novel cysteine-rich cell-penetrating peptide for cytosolic delivery of cargoes.
    Jha D; Mishra R; Gottschalk S; Wiesmüller KH; Ugurbil K; Maier ME; Engelmann J
    Bioconjug Chem; 2011 Mar; 22(3):319-28. PubMed ID: 21319732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclization of a cell-penetrating peptide via click-chemistry increases proteolytic resistance and improves drug delivery.
    Reichart F; Horn M; Neundorf I
    J Pept Sci; 2016 Jun; 22(6):421-6. PubMed ID: 27197760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclopropane pipecolic acids as templates for linear and cyclic peptidomimetics: application in the synthesis of an Arg-Gly-Asp (RGD)-containing peptide as an αvβ3 integrin ligand.
    Sernissi L; Petrović M; Scarpi D; Guarna A; Trabocchi A; Bianchini F; Occhiato EG
    Chemistry; 2014 Aug; 20(35):11187-203. PubMed ID: 25069617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
    He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
    Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.